Health Professional Radio - Podcast

Joseph Hernandez, Founder and CEO of Blue Water Vaccines discusses the company's development of a universal influenza vaccine. Current research and development of this vaccine show that two doses are needed to focus the immune response on the regions of limited variability, which could provide life-long protection against influenza strains for most patients in comparison to the current yearly vaccine that’s administered, which only help about 50% of those who get it.